AAO 2024: New gene therapy shows promise for treatment of …
Oct 20, 2024 · Key Takeaways. MCO-010 gene therapy improves vision in retinitis pigmentosa patients, with up to 50% gaining significant visual acuity. The therapy is mutation-agnostic, …
AAO 2024: Long-term low-dose antiviral treatment benefits …
Oct 19, 2024 · Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles …
Ophthalmology Times - Ophthalmology news, articles, and events
Chen and colleagues conducted a longitudinal study that included patients with high myopia who were followed for 10 years. Detailed ophthalmic examinations were conducted at the baseline …
What increased depth of focus can mean to your monofocal IOL …
Dec 31, 2024 · Enhanced monofocal IOLs provide a slight depth-of-focus boost without compromising contrast, making them a versatile choice for patients seeking improved distance …
ASCRS 2024: What advancements in Light Adjustable Lens …
Apr 10, 2024 · Neda Nikpoor, MD, spoke to Ophthalmology Times about her presentation on the Light Adjustable Lens during an ASCRS symposia on IOL calculations.. Video Transcript. …
LumiThera’s Valeda Light Delivery System receives marketing ...
Nov 6, 2024 · LumiThera Inc. announced the US Food & Drug Administration (FDA) has authorized marketing of Valeda Light Delivery System for the treatment of patients with dry …
Promising non-surgical treatment for early cataracts: Insights from …
Nov 16, 2024 · Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 …
Treating chalazion with IPL therapy - Ophthalmology Times
Jul 26, 2019 · Editor’s Note: Welcome to “Let's Chat,” a blog series featuring contributions from members of the ophthalmic community.These blogs are an opportunity for ophthalmic …
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
Oct 14, 2024 · Key Takeaways. enVista Envy IOLs provide a continuous range of vision with high dysphotopsia tolerance, enhancing cataract surgery outcomes. U.S. and Canadian trials …
Johnson & Johnson launches TECNIS Odyssey IOL in US
Oct 1, 2024 · Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL), TECNIS Odyssey, in the US.. The TECNIS Odyssey IOL is a new full vision range …